nature.com search

Loading Filters

Showing 1–26 of 26 results

Loading Filters

Reviews | 1 January 2007
Strategies for therapy in acute ischemic stroke
- Dr James Kennedy gained his medical degree from...
- Alastair M Buchan
- & James Kennedy
Nature Clinical Practice Neurology 3 , 2–3

Rights & permissionsfor article Strategies for therapy in acute ischemic stroke . Opens in a new window.
Research | 15 June 2004
Analysis of the novel TPH2 gene in bipolar disorder and suicidality
- James_Kennedy@camh.net
- V De Luca
- , D J Mueller
- , S Tharmalingam
- , N King
- & J L Kennedy
Molecular Psychiatry 9 , 896–897

Rights & permissionsfor article Analysis of the novel TPH2 gene in bipolar disorder and suicidality . Opens in a new window.
Research | 1 October 2003
Investigation of polymorphism in the MDR1 gene and antidepressant-induced mania
- James_Kennedy@camh.net
- V De Luca
- , E Mundo
- , J Trakalo
- , G W H Wong
- & J L Kennedy
The Pharmacogenomics Journal 3 , 297–299

Rights & permissionsfor article Investigation of polymorphism in the MDR1 gene and antidepressant-induced mania . Opens in a new window.
Research | 1 February 2003
Association between the BDNF gene and schizophrenia
- James_Kennedy@camh.net
- P Muglia
- , A M Vicente
- , M Verga
- , N King
- , F Macciardi
- & J L Kennedy
Molecular Psychiatry 8 , 147–148

Rights & permissionsfor article Association between the BDNF gene and schizophrenia . Opens in a new window.
Research | 1 August 2002
5HT1Dβ Receptor gene implicated in the pathogenesis of Obsessive-Compulsive Disorder: further evidence from a family-based association study
- James_Kennedy@CAMH.net
- E Mundo
- , M A Richter
- , G Zai
- , F Sam
- , J McBride
- , F Macciardi
- & J L Kennedy
Molecular Psychiatry 7 , 805–809

Rights & permissionsfor article 5HT1Dβ Receptor gene implicated in the pathogenesis of Obsessive-Compulsive Disorder: further evidence from a family-based association study . Opens in a new window.
Research | 1 September 2002
Dopamine D4 receptor and tyrosine hydroxylase genes in bipolar disorder: evidence for a role of DRD4
- James_Kennedy@camh.net
- P Muglia
- , A Petronis
- , E Mundo
- , S Lander
- , T Cate
- & J L Kennedy
Molecular Psychiatry 7 , 860–866

Rights & permissionsfor article Dopamine D4 receptor and tyrosine hydroxylase genes in bipolar disorder: evidence for a role of DRD4 . Opens in a new window.
Research | 1 January 2003
The serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder
- james_kennedy@camh.net
- J F Quist
- , C L Barr
- , R Schachar
- , W Roberts
- , M Malone
- , R Tannock
- , V S Basile
- , J Beitchman
- & J L Kennedy
Molecular Psychiatry 8 , 98–102

Rights & permissionsfor article The serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder . Opens in a new window.
Research | 21 April 2004
Evidence of Association between Smoking and α7 Nicotinic Receptor Subunit Gene in Schizophrenia Patients
- James_Kennedy@camh.net
Neuropsychopharmacology 29 , 1522–1526

Rights & permissionsfor article Evidence of Association between Smoking and α7 Nicotinic Receptor Subunit Gene in Schizophrenia Patients . Opens in a new window.
Research | 28 March 2001
The 5HT1Dβ Receptor Gene in Bipolar Disorder: A Family-based Association Study
- james_kennedy@camh.net
- Emanuela Mundo
- , Gwyneth Zai
- , Lisa Lee
- , Sagar V Parikh
- & James L Kennedy
Neuropsychopharmacology 25 , 608–613

Rights & permissionsfor article The 5HT1Dβ Receptor Gene in Bipolar Disorder: A Family-based Association Study . Opens in a new window.
Research | 1 September 2000
Evidence for the serotonin HTR2A receptor gene as a susceptibility factor in attention deficit hyperactivity disorder (ADHD)
- james_kennedy@camh.net
- J F Quist
- , C L Barr
- , R Schachar
- , W Roberts
- , M Malone
- , R Tannock
- , V S Basile
- , J Beitchman
- & J L Kennedy
Molecular Psychiatry 5 , 537–541

Rights & permissionsfor article Evidence for the serotonin HTR2A receptor gene as a susceptibility factor in attention deficit hyperactivity disorder (ADHD) . Opens in a new window.
Research | 11 March 2002
A Quantitative Trait Locus Analysis of the Dopamine Transporter Gene in Adults with ADHD
- james_kennedy@camh.net
Neuropsychopharmacology 27 , 655–662

Rights & permissionsfor article A Quantitative Trait Locus Analysis of the Dopamine Transporter Gene in Adults with ADHD . Opens in a new window.
Research | 24 February 2009
Association study of tardive dyskinesia and five DRD4 polymorphisms in schizophrenia patients
- James_Kennedy@camh.net
- C C Zai
- , A K Tiwari
- , V Basile
- , V De Luca
- , D J Müller
- , N King
- , A N Voineskos
- , G Remington
- , H Y Meltzer
- , J A Lieberman
- , S G Potkin
- & J L Kennedy
The Pharmacogenomics Journal 9 , 168–174

Rights & permissionsfor article Association study of tardive dyskinesia and five DRD4 polymorphisms in schizophrenia patients . Opens in a new window.
Research | 8 March 2006
Association of the Val158Met Catechol O-Methyltransferase Genetic Polymorphism with Panic Disorder
- James_Kennedy@camh.net
- Claudia Rothe
- , Diana Koszycki
- , Jacques Bradwejn
- , Nicole King
- , Vincenzo Deluca
- , Subi Tharmalingam
- , Fabio Macciardi
- , Jürgen Deckert
- & James L Kennedy
Neuropsychopharmacology 31 , 2237–2242

Rights & permissionsfor article Association of the Val158Met Catechol O-Methyltransferase Genetic Polymorphism with Panic Disorder . Opens in a new window.
Research | 25 January 2011
Association study of Cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia
- James_Kennedy@camh.net
- A K Tiwari
- , C C Zai
- , O Likhodi
- , A N Voineskos
- , H Y Meltzer
- , J A Lieberman
- , S G Potkin
- , G Remington
- , D J Müller
- & J L Kennedy
The Pharmacogenomics Journal 12 , 260–266

Rights & permissionsfor article Association study of Cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia . Opens in a new window.
Research | 1 February 2003
Evidence that the N-methyl-D-aspartate subunit 1 receptor gene (GRIN1) confers susceptibility to bipolar disorder
- james_kennedy@CAMH.net
- E Mundo
- , S Tharmalingham
- , M Neves-Pereira
- , E J Dalton
- , F Macciardi
- , S V Parikh
- , A Bolonna
- , R W Kerwin
- , M J Arranz
- , A J Makoff
- & J L Kennedy
Molecular Psychiatry 8 , 241–245

Rights & permissionsfor article Evidence that the N-methyl-D-aspartate subunit 1 receptor gene (GRIN1) confers susceptibility to bipolar disorder . Opens in a new window.
Research | 1 March 2001
Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia
- James_Kennedy@camh.net
- V S Basile
- , V Ozdemir
- , M Masellis
- , H Y Meltzer
- , J A Lieberman
- , S G Potkin
- , F M Macciardi
- , A Petronis
- & J L Kennedy
Molecular Psychiatry 6 , 230–234

Rights & permissionsfor article Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia . Opens in a new window.
Correspondence | 11 June 2013
Exome sequence analysis of Finnish patients with clozapine-induced agranulocytosis
- James_Kennedy@camh.net
- A K Tiwari
- , A C Need
- , F W Lohoff
- , C C Zai
- , N I Chowdhury
- , D J Müller
- , A Putkonen
- , E Repo-Tiihonen
- , T Hallikainen
- , A E Anil Yağcıoğlu
- , J Tiihonen
- , J L Kennedy
- & H Y Meltzer
Molecular Psychiatry 19 , 403–405

Rights & permissionsfor article Exome sequence analysis of Finnish patients with clozapine-induced agranulocytosis . Opens in a new window.
Research | 7 February 2012
Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene
- james_kennedy@camh.net
- N I Chowdhury
- , A K Tiwari
- , R P Souza
- , C C Zai
- , S A Shaikh
- , S Chen
- , F Liu
- , J A Lieberman
- , H Y Meltzer
- , A K Malhotra
- , J L Kennedy
- & D J Müller
The Pharmacogenomics Journal 13 , 272–279

Rights & permissionsfor article Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene . Opens in a new window.
Research | 17 August 2010
Systematic analysis of dopamine receptor genes (DRD1–DRD5) in antipsychotic-induced weight gain
- James_Kennedy@camh.net
- D J Müller
- , C C Zai
- , M Sicard
- , E Remington
- , R P Souza
- , A K Tiwari
- , R Hwang
- , O Likhodi
- , S Shaikh
- , N Freeman
- , T Arenovich
- , A Heinz
- , H Y Meltzer
- , J A Lieberman
- & J L Kennedy
The Pharmacogenomics Journal 12 , 156–164

Rights & permissionsfor article Systematic analysis of dopamine receptor genes (DRD1–DRD5) in antipsychotic-induced weight gain . Opens in a new window.
Research | 1 February 2003
Identification of candidate genes for psychosis in rat models, and possible association between schizophrenia and the 14-3-3η gene
- James_Kennedy@camh.net
- A H C Wong
- , F Macciardi
- , T Klempan
- , W Kawczynski
- , C L Barr
- , S Lakatoo
- , M Wong
- , C Buckle
- , J Trakalo
- , E Boffa
- , J Oak
- , M-H Azevedo
- , A Dourado
- , I Coelho
- , A Macedo
- , A Vicente
- , J Valente
- , C P Ferreira
- , M T Pato
- , C N Pato
- , J L Kennedy
- & H H M Van Tol
Molecular Psychiatry 8 , 156–166

Rights & permissionsfor article Identification of candidate genes for psychosis in rat models, and possible association between schizophrenia and the 14-3-3η gene . Opens in a new window.
Research | 22 December 2009
Effect of dopamine D3 receptor gene polymorphisms and clozapine treatment response: exploratory analysis of nine polymorphisms and meta-analysis of the Ser9Gly variant
- james_kennedy@camh.net
- R Hwang
- , C Zai
- , A Tiwari
- , D J Müller
- , M J Arranz
- , A G Morris
- , P J McKenna
- , J Munro
- , S G Potkin
- , J A Lieberman
- , H Y Meltzer
- & J L Kennedy
The Pharmacogenomics Journal 10 , 200–218

Rights & permissionsfor article Effect of dopamine D3 receptor gene polymorphisms and clozapine treatment response: exploratory analysis of nine polymorphisms and meta-analysis of the Ser9Gly variant . Opens in a new window.
Research | 25 March 2004
Clinical implications of pharmacogenomics for tardive dyskinesia
- james_kennedy@camh.net
- D J Müller
- , T Shinkai
- , V De Luca
- & J L Kennedy
The Pharmacogenomics Journal 4 , 77–87

Rights & permissionsfor article Clinical implications of pharmacogenomics for tardive dyskinesia . Opens in a new window.
Research | 27 January 2010
A Common Polymorphism in the Cannabinoid Receptor 1 (CNR1) Gene is Associated with Antipsychotic-Induced Weight Gain in Schizophrenia
- James_Kennedy@camh.net
- Arun K Tiwari
- , Clement C Zai
- , Olga Likhodi
- , Annika Lisker
- , Deepika Singh
- , Renan P Souza
- , Poonam Batra
- , Syed H E Zaidi
- , Sheng Chen
- , Fang Liu
- , Imke Puls
- , Herbert Y Meltzer
- , Jeffrey A Lieberman
- , James L Kennedy
- & Daniel J Müller
Neuropsychopharmacology 35 , 1315–1324

Rights & permissionsfor article A Common Polymorphism in the Cannabinoid Receptor 1 (CNR1) Gene is Associated with Antipsychotic-Induced Weight Gain in Schizophrenia . Opens in a new window.
Correspondence | 28 November 2007
Multiple variants of the DRD3, but not BDNF gene, influence age-at-onset of schizophrenia
- james_kennedy@camh.net
- J Renou
- , V De Luca
- , C C Zai
- , N Bulgin
- , G Remington
- , H Y Meltzer
- , J A Lieberman
- , B Le Foll
- & J L Kennedy
Molecular Psychiatry 12 , 1058–1060

Rights & permissionsfor article Multiple variants of the DRD3, but not BDNF gene, influence age-at-onset of schizophrenia . Opens in a new window.
Correspondence | 27 August 2007
Meta-analysis of two dopamine D₂ receptor gene polymorphisms with tardive dyskinesia in schizophrenia patients
- James_Kennedy@camh.net
- C C Zai
- , V De Luca
- , R W Hwang
- , A Voineskos
- , D J Müller
- , G Remington
- & J L Kennedy
Molecular Psychiatry 12 , 794–795

Rights & permissionsfor article Meta-analysis of two dopamine D2 receptor gene polymorphisms with tardive dyskinesia in schizophrenia patients . Opens in a new window.
Reviews | 22 March 2016
Mechanisms of the placebo effect in pain and psychiatric disorders
- James.Kennedy@camh.ca
- R D Holmes
- , A K Tiwari
- & J L Kennedy
The Pharmacogenomics Journal 16 , 491–500

Rights & permissionsfor article Mechanisms of the placebo effect in pain and psychiatric disorders . Opens in a new window.

Refine your results by…

Filters

Filter By:

Strategies for therapy in acute ischemic stroke

Analysis of the novel TPH2 gene in bipolar disorder and suicidality

Investigation of polymorphism in the MDR1 gene and antidepressant-induced mania

Association between the BDNF gene and schizophrenia

5HT1Dβ Receptor gene implicated in the pathogenesis of Obsessive-Compulsive Disorder: further evidence from a family-based association study

Dopamine D4 receptor and tyrosine hydroxylase genes in bipolar disorder: evidence for a role of DRD4

The serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder

Evidence of Association between Smoking and α7 Nicotinic Receptor Subunit Gene in Schizophrenia Patients

The 5HT1Dβ Receptor Gene in Bipolar Disorder: A Family-based Association Study

Evidence for the serotonin HTR2A receptor gene as a susceptibility factor in attention deficit hyperactivity disorder (ADHD)

A Quantitative Trait Locus Analysis of the Dopamine Transporter Gene in Adults with ADHD

Association study of tardive dyskinesia and five DRD4 polymorphisms in schizophrenia patients

Association of the Val158Met Catechol O-Methyltransferase Genetic Polymorphism with Panic Disorder

Association study of Cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia

Evidence that the N-methyl-D-aspartate subunit 1 receptor gene (GRIN1) confers susceptibility to bipolar disorder

Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia

Exome sequence analysis of Finnish patients with clozapine-induced agranulocytosis

Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene

Systematic analysis of dopamine receptor genes (DRD1–DRD5) in antipsychotic-induced weight gain

Identification of candidate genes for psychosis in rat models, and possible association between schizophrenia and the 14-3-3η gene

Effect of dopamine D3 receptor gene polymorphisms and clozapine treatment response: exploratory analysis of nine polymorphisms and meta-analysis of the Ser9Gly variant

Clinical implications of pharmacogenomics for tardive dyskinesia

A Common Polymorphism in the Cannabinoid Receptor 1 (CNR1) Gene is Associated with Antipsychotic-Induced Weight Gain in Schizophrenia

Multiple variants of the DRD3, but not BDNF gene, influence age-at-onset of schizophrenia

Meta-analysis of two dopamine D₂ receptor gene polymorphisms with tardive dyskinesia in schizophrenia patients

Mechanisms of the placebo effect in pain and psychiatric disorders

Quick links

Refine your results by…

Filters ​

Filter By:

Search

Quick links

Filters